The ESMO Targeted Anticancer Therapies (TAT) Congress 2027 will take place from February 22–24, 2027, at the Palais des Congrès de Paris in Paris, France.

Organized by the European Society for Medical Oncology (ESMO), the congress will bring together clinicians, researchers, and experts in drug development to discuss advances in early-phase oncology research and innovative anticancer therapies.

The meeting will focus on the development and clinical translation of targeted anticancer therapies, including molecularly driven drug development, precision oncology approaches, biomarkers, early clinical trials, and emerging treatment strategies. The congress provides a platform for researchers, clinicians, and industry experts to exchange knowledge on new therapeutic approaches and their path from discovery to patient care.